Stereotactic radiosurgery for brain metastases from malignant melanoma.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4553636)

Published in Surg Neurol Int on August 20, 2015

Authors

Sebastian M Christ1, Anand Mahadevan2, Scott R Floyd3, Fred C Lam4, Clark C Chen5, Eric T Wong6, Ekkehard M Kasper1

Author Affiliations

1: Division of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street, Boston, MA 02215, USA.
2: Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave., Boston, MA 02215, USA.
3: Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave., Boston, MA 02215, USA ; Koch Institute for Integrative Cancer Biology, Massachusetts Institute of Technology, 500 Main Street, Cambridge, MA 02139, USA.
4: Koch Institute for Integrative Cancer Biology, Massachusetts Institute of Technology, 500 Main Street, Cambridge, MA 02139, USA.
5: Division of Neurosurgery, University of California Sand Diego, 200 West Arbor Drive, San Diego, CA 92103, USA.
6: Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave., Boston, MA 02215, USA.

Articles citing this

Melanoma central nervous system metastases: current approaches, challenges, and opportunities. Pigment Cell Melanoma Res (2016) 0.81

Articles cited by this

Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol (2009) 9.90

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys (1997) 8.58

Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. J Clin Oncol (2008) 8.09

A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med (1990) 7.92

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet (2004) 7.78

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA (1998) 6.49

Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol (2010) 6.15

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol (2011) 4.12

Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg (1996) 3.75

Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys (1999) 2.84

The management of brain metastases. Cancer Treat Rev (2003) 2.70

Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol (2004) 2.36

Multidisciplinary management of brain metastases. Oncologist (2007) 2.15

Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer (1978) 2.04

Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys (2000) 1.88

Surgical treatment of multiple brain metastases. J Neurosurg (1993) 1.61

A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys (2003) 1.55

Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev (2005) 1.54

Management of cerebral metastasis: evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy. Eur J Cancer (2010) 1.39

Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys (2004) 1.25

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys (1998) 1.22

Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. J Neurosurg (2010) 1.20

Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery (1999) 1.10

Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys (2002) 1.07

Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis. Am J Clin Oncol (2010) 1.06

Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases. Cancer (2007) 1.06

Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma. J Neurosurg (2008) 1.03

Whole brain radiotherapy after local treatment of brain metastases in melanoma patients--a randomised phase III trial. BMC Cancer (2011) 1.03

Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.02

Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma. Neurosurgery (2009) 0.97

Melanoma in the brain: biology and therapeutic options. Melanoma Res (2012) 0.95

Surgical treatment of brain metastasis: a review. Clin Neurol Neurosurg (2011) 0.92

Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents. Onco Targets Ther (2011) 0.88

Linear accelerator based stereotactic radiosurgery for melanoma brain metastases. J Cancer Res Ther (2012) 0.87

Outcomes of patients with brain metastases from melanoma and renal cell carcinoma after primary stereotactic radiosurgery. Clin Neurosurg (2008) 0.84

A concise review of the efficacy of stereotactic radiosurgery in the management of melanoma and renal cell carcinoma brain metastases. World J Surg Oncol (2012) 0.83

Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors. J Neurooncol (2005) 0.82

Management of metastatic melanoma patients with brain metastases. Curr Oncol Rep (2007) 0.79

Does overall treatment time impact on survival after whole-brain radiotherapy for brain metastases? Clin Transl Oncol (2011) 0.77